Defining Lawful Hemp In US Soon On Regulatory And Legislative Menu For Different Cooks

Whether Democrat Harris or Republican Trump is in White House or which party has majority in either chamber of Congress, the FDA’s conundrum will continue around a regulatory pathway for allowing use of ingredients derived from hemp in supplements.

(Source: Shutterstock/Citeline)

When the next occupant of the White House moves in and the 435 House and 100 Senate members start the 119th session of Congress in January, on their plates will be a regulatory question plaguing lawmakers and executive agencies since 2019.

Whether Democrat Kamala Harris or Republican Donald Trump is in the White House or which party has a majority in either or both chambers of Congress, the Food and Drug...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Legislation

More from Beauty

Beauty Industry Not Taking Advantage Of CBP’s Duty Drawback – IBA Conference

 

US Customs and Border Protection’s program allowing companies to recoup fees for imported goods that were destroyed or exported is applicable in the case of most of President Trump’s reciprocal tariffs. However, most cosmetic companies don’t make use of it.

Estee Lauder Taps Iconic Creative Director For MAC, Indian Personal Care Firm Appoints Chief Commercial Officer For Hair Care; Beauty News

 

MAC Cosmetics Appoints ‘Iconic’ Creative Director Nicola Formichetti as global creative director, while Revlon Consumer Products LLC partners with four-time GRAMMY-nominated artist, Ice Spice, in a “major step” in the revitalization of Revlon’s fragrance business.

Shiseido’s Key Priorities: Recover Drunk Elephant, Accelerate NARS Amid US Prestige Slowdown

 

Shiseido’s Drunk Elephant premium skin care range – acquired in 2019 – and its NARS brand dragged sales in the Americas region down almost 20% in the first quarter, the firm reported in a 12 May earnings presentation.